BBPWM
NVAX icon

Blue Bell Private Wealth Management’s Novavax NVAX Stock Holding History

Blue Bell Private Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30
Closed -$1K – 724
2022
Q3 		$1K Hold
30
– – ﹤0.01% 694
2022
Q2 		$2K Sell
30
-10
-25% -$518 ﹤0.01% 646
2022
Q1 		$3K Buy
40
+5
+14% +$446 ﹤0.01% 635
2021
Q4 		$5K Buy
+35
New +$6.01K ﹤0.01% 541

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blue Bell Private Wealth Management's NVAX Position: Q4 2022 in Review

Blue Bell Private Wealth Management sold out of Novavax (NVAX) in Q4 2022, closing a stake of 30 shares — an estimated $1K sold.

Blue Bell Private Wealth Management first reported a position in NVAX in Q4 2021 and held it in 4 quarters. The position peaked at $5K in Q4 2021. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

  • Blue Bell Private Wealth Management reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 30 Novavax shares in Q4 2022, an estimated $1K.
  • Blue Bell Private Wealth Management first reported a position in Novavax in Q4 2021 and held it in 4 quarters.
  • Blue Bell Private Wealth Management's Novavax position peaked at $5K in Q4 2021.
  • 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.